Abstract:ObjectiveTo construct a recombinant Listeria ivanovii (LI) strain that expressed Mycobacterium tuberculosis (MTB) specific antigen protein as a novel multistage tuberculosis (TB) vaccine candidate, and evaluate the biosafety and immunogenicity in mouse model.MethodsT cell epitopes of four genes related to different stages of MTB infection were fused in series to form an antigen gene, i.e. the multistage antigen gene (named msv). Then msv was inserted into the targeting plasmid that contained LI homologous sequences. Recombinant LI strain was obtained by transfecting LI with targeting plasmid and screening the recombinant LI strain that carried msv in the genome after series of homologous gene recombination processes. The growth rate of the recombinant LI strain in vitro was observed and the expression of target protein was verified by Western blot. The 50% lethal dose (LD 50) of the recombinant strain to C57BL/6 mice was measured. Mice were intravenously inoculated with vaccine candidate in dose of 0.1×LD 50.The serum alanine aminotransferase (ALT) levels, bacterial load in organs, and organ pathological sections before and 1, 2, 3, 5, 7, 14 d after vaccination were used to evaluate the safety of vaccine candidate strain. To analyze the immunogenicity of vaccine candidate strain, mice were intravenously inoculated with LI- msv, LI, and NS respectively. Nine days post immunization, the spleens were isolated under sterile conditions and splenocytes were collected and stimulated. Lyphocytes which secret specific cytokines, interferon (IFN)-γ, tumor necrosis factor (TNF)-α and interleukin (IL)-2 were analyzed by flow cytometry.ResultsA recombinant strain named LI- msv which was capable of expressing the multistage TB antigen protein was successfully constructed. The LD 50 value of LI- msv for C57BL/6 mice (i.v.) was 3.3×10 8 CFU. After intravenously immunized the mice, this strain mainly multiplied in the liver and spleen, and was cleared at 7 d post innoculation. Such infection process caused transient pathological damages of the liver and spleen. Results of flow cytometry showed specific IFN-γ + CD4 + and IFN-γ + CD8 +T lymphocytes were successfully induced in LI -msv immunized mice spleen lymphocytes. The frequency of IFN-γ positive CD4 + and CD8 +T cells was significantly higher than those of vector control group and NS control group ( P<0.005). Additionally, the frequency of specific TNF-α + CD4 + T cell in LI -msv immunized group was significantly higher than that of vector control ( P<0.01) and NS control group ( P<0.005), and TNF-α + CD8 + T cell frequency obviously increased than NS control group ( P<0.005).ConclusionsA novel multistage TB vaccine candidate expressing TB multistage antigen based on LI was successfully constructed. This vaccine candidate is safe and can induce specific cellular immune response to some extent. It is promising to be further studied as a candidate vaccine against tuberculosis.

[Construction, Identification and Immunoreactivity of Mycobacterium Tuberculosis DNA Vaccine Pvax1/esat-6 Plasmid].

[Construction and Evaluation of a Tuberculosis Multistage Vaccine Candidate Based on Recombinant Listeria Ivanovii].

ESAT-6 DNA Vaccine for Mycobacterium Tuberculosis and Its Humoral and T-cell Response As Well As Its Protective Efficacy

Construction of the esat-6 Gene vaccine of Mycobacterium tuberculosis and its immunogenicity

Immunogenicity of DNA vaccine expressing ESAT6-CFP10 fusion protein of Mycobacterium tuberculosis

Construction and immunogenicity of Mycobacterium tuberculosis subunit vaccine ESAT6-RpfE

Construction of Multivalent DNA Vaccines Formycobacterium Tuberculosis and Its Immunogenicity

Construction and Immunogenicity of the Dna Vaccine of Mycobacterium Tuberculosis Dormancy Antigen Rv1733c

Expression And Purification Of Mycobacterium Tuberculosis Esat-6 And Mpt64 Fusion Protein And Its Immunoprophylactic Potential In Mouse Model

The Construction of Ag85A and ESAT6 Co-Expression Eukaryotic Plasmid

Ubiqutin and ESAT6 Antigen Fusion Gene DNA Vaccine Induced Stronger Cellular Immune Response in Mice

[Construction and Immunogenicity of DNA Vaccine Encoding Secreted Form of Ag85B Protein of Mycobacterium Tuberculosis].

Construction and immunogenicity of the DNA vaccine of dormancy related antigen Rv1733c of Mycobacterium tuberculosis

Immune Responses and Protective Efficacy of the Gene Vaccine Expressing Ag85B and ESAT6 Fusion Protein Frommycobacterium Tuberculosis

The cellular immune response and protective efficacy against tuberculosis infection of a novel mycobacterium tuberculosis DNA vaccine p846

Construction,expression and gene immunization of eukaryotic expression vector containing cfp10 of Mycobacterium tuberculosis

Incorporation of immunostimulatory motifs in the transcribed region of a plasmid DNA vaccine enhances Th1 immune responses and therapeutic effect against Mycobacterium tuberculosis in mice.

Construction, Expression and Identification of a Recombinant BCG Vaccine Secreting the Fusion Protein CFP10- ESAT6

Construction of Secreted Protein ESAT6 and MPT64 of Mycobacterium Tuberculosis to Evaluate Its Applicability in Serological Diagnosis

[Construction of Ag85B DNA Vaccine for Mycobacterium Tuberculosis and Its Immunogenicities].

A novel DNA vaccine containing multiple TB-specific epitopes casted in a natural structure (ECANS) confers protective immunity against pulmonary mycobacterial challenge.